CAS 8002-03-7|Peanut oil
| Common Name | Peanut oil | ||
|---|---|---|---|
| CAS Number | 8002-03-7 | Molecular Weight | / |
| Density | 0.91 g/mL at 25 °C(lit.) | Boiling Point | / |
| Molecular Formula | / | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | 283 °C |
Names
| Name | Peanut oil |
|---|---|
| Synonym | More Synonyms |
Peanut oil BiologicalActivity
| Description | Peanut Oil can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| References | [1]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99. |
Chemical & Physical Properties
| Density | 0.91 g/mL at 25 °C(lit.) |
|---|---|
| Flash Point | 283 °C |
| Appearance of Characters | Viscous Liquid | Clear yellow |
| Index of Refraction | n20/D 1.470 |
| Storage condition | 2-8°C |
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves |
|---|---|
| Safety Phrases | 24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | - |
| RTECS | RX2830000 |
Articles31
More Articles| Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis. J. Mol. Cell. Cardiol. 88 , 1-13, (2015) Gap junctions (GJ) are intercellular channels composed of connexin subunits that play a critical role in a diverse number of cellular processes in all tissue types. In the heart, GJs mediate electrica... | |
| Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method. Int. J. Pharm. 409(1-2) , 89-95, (2011) A new o/o/o-solvent extraction microencapsulation method based on less toxic solvents is presented in this study. The drug is dissolved/dispersed into a poly(D,L-lactide)/or poly (D,L-lactide-co-glyco... | |
| Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone. Drug Dev. Ind. Pharm. 39(1) , 39-50, (2013) The efficacy of oral risperidone treatment in prevention of schizophrenia is well known. However, oral side effects and patient compliance is always a problem for schizophrenics. In this study, risper... |
Synonyms
| MFCD00131805 |
